Insulin-Like Growth Factor (IGF) Binding Protein-1 is an Antigonadotropin: Evidence that Optimal Follicle-Stimulating Hormone Action in Ovarian Granulosa Cells is Contingent upon Amplification by Endogenously-Derived IGFs
Implicit in the antigonadotropic property of IGFBPs is the presumption that they sequester endogenously-generated IGFs thereby diminishing their access to cognate cell surface receptors and hence their cellular hormonal action. This communication examines this concept and the relevance of endogenous IGF to FSH action.
Key WordsIGF Ovary Binding Proteins Gonadotropins
Unable to display preview. Download preview PDF.
- 4.M.A. De Vroede, L.Y.-H. Tseng, P.G. Katsoyannis, S.P. Nissley, and M.M. Rechler, Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulin-like growth factor carrier proteins released to the incubation media, J. Clin Invest. 77:602–613 (1986).CrossRefGoogle Scholar
- 7.W.H. Busby Jr., D.G. Klapper, and D.R. Clemmons, Purification of a 31,000-Dalton insulin-like growth factor binding protein from human amniotic fluid, J. Biol. Chem. 263:14203–14210 (1988).Google Scholar
- 13.T.A. Bicsak, M. Shimonaka, M. Malkowski, and N. Ling,Insulin-like growth factor binding protein (IGF-BP) inhibition of granulosa cell function: Effect on cyclic adenosine 3’, 3’-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody, Endocrinology 126:2184–2189 (1990).PubMedCrossRefGoogle Scholar